Pharmaceuticals

University of Maryland Medical Center Launches Genetic-Testing Program For Cardiac Stent Patients

Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center (UMMC) now can receive long-term therapy based on information found in their genes. As part of a new personalized medicine initiative, the med...

First Implant Made for Barostim neo Device to Treat Hypertension

Prof. Dr. Béla Merkely and Dr. Péter Sótonyi at Semmelweis Egyetem Kardiológiai Központ in Hungary completed the first patient implant of the Barostim neo device for hypertension. Barostim neo is a small, easy...

FDA Approves Kcentra for the Urgent Reversal of Anticoagulation in Adults with Major Bleeding

The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K antagonist (VKA) anticoagulation in adults with acute major bleeding. 

Newly Approved Blood Thinner May Increase Viral Infections

A study led by researchers at the University of North Carolina indicates a newly approved blood thinner blocks a key component of the human blood clotting system and may increase the risk and severity of certain viral infections, including flu and...

St. Jude Medical Initiates First U.S. Clinical Study of the...
St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval to begin the EnligHTN IV Renal Denervation Study, the first U.S. trial using...
Boston Scientific Vessix Renal Denervation System Hypertension Therapies
New Data Shows Sustained Blood Pressure Reduction With...
Boston Scientific Corporation reported interim data from the REDUCE-HTN clinical program, which demonstrated a significant and sustained reduction in the blood...
One-Year Data Shows Blood Pressure Reduction With EnligHTN...
June 3, 2013 — St. Jude Medical Inc. announced the company’s EnligHTN multi-electrode renal denervation system provides a safe, rapid and...
Six-Month Data Reported for WAVE I Study of Renal...
Kona Medical announced three and six month results from the WAVE I study, a first-in-man study evaluating the safety and efficacy of Kona Medical’s ...
Merck FDA Approval Liptruzet
Liptruzet (pronounced LIP-true-zett) contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin, currently one
FDA Approves Kcentra for the Urgent Reversal of Anticoagulation in Adults with Major Bleeding
The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K...
Atherotech Diagnostics Lab Adds Corgenix AspirinWorks Test for Aspirin Effect
Corgenix Medical Corp. has announced that Atherotech Diagnostics Lab will carry its AspirinWorks Test for determining...
View All »

Articles

University of Maryland Medical Center Genetic-Testing Program Cardiac Stent
University of Maryland Medical Center Launches Genetic-...
Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center (UMMC) now can receive long-term therapy based on...
First Implant Made for Barostim neo Device to Treat...
Prof. Dr. Béla Merkely and Dr. Péter Sótonyi at Semmelweis Egyetem Kardiológiai Központ in Hungary completed the first patient implant of the Barostim neo...
Merck FDA Approval Liptruzet
FDA Approves Liptruzet (ezetimibe and atorvastatin), a to...
Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved Liptruzet (ezetimibe and...
FDA Approves Kcentra for the Urgent Reversal of...
The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K antagonist (VKA)...

Video Center

view all Videos »

New Trends and Technology in Electrophysiology from HRS 2013
The Heart Rhythm Society (HRS) 2013 scientific sessions covered the latest research and technology...
1 week 6 days ago
The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
15 weeks 10 hours ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
19 weeks 2 days ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...

Comparison Charts

Sorry there is no data available